找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Lung Cancer and Personalized Medicine; Current Knowledge an Aamir Ahmad,Shirish Gadgeel Book 2016 The Editor(s) (if applicable) and The Aut

[復(fù)制鏈接]
樓主: 導(dǎo)彈
31#
發(fā)表于 2025-3-26 22:38:25 | 只看該作者
32#
發(fā)表于 2025-3-27 02:04:18 | 只看該作者
Bernhard Biersack,Rainer Schobert emission band. Instead, crests and crevices, rifts and ridges showed up in the recorded spectra. Soon these observed features were traced to either very weak absorption of matter or spurious interference inside the laser resonator [1]. This interpretation suggested that this ultra-sensitive respons
33#
發(fā)表于 2025-3-27 09:08:48 | 只看該作者
34#
發(fā)表于 2025-3-27 11:07:34 | 只看該作者
35#
發(fā)表于 2025-3-27 13:39:28 | 只看該作者
36#
發(fā)表于 2025-3-27 20:52:55 | 只看該作者
37#
發(fā)表于 2025-3-28 00:02:07 | 只看該作者
Immune Therapy,as shown that anti-tumor immune responses can occur in lung cancer patients, paving the way for lung cancer as a novel target for immunotherapy. In order to take full advantage of the potential of immunotherapy, research is focusing on the presence and function of various immunological cell types in
38#
發(fā)表于 2025-3-28 02:28:28 | 只看該作者
39#
發(fā)表于 2025-3-28 09:10:08 | 只看該作者
Target Therapy in Lung Cancer, Health Organization (WHO) typing system [1]. Because these variants have differing genetic and biological properties correct classification of lung cancer is necessary to assure that lung cancer patients receive optimum management. Due to the recent understanding that histologic typing and . mutati
40#
發(fā)表于 2025-3-28 11:30:41 | 只看該作者
Mechanisms of Resistance to EGFR Tyrosine Kinase Inhibitors and Therapeutic Approaches: An Update, mechanisms namely secondary mutation T790M in EGFR and cMET amplification. Other molecular mediators which contribute towards TKI resistance include the activation of compensatory growth signaling, epithelial mesenchymal transition and microRNAs regulating EGFR and cMET levels. In this chapter, we
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-8 09:29
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
多伦县| 凤城市| 乌鲁木齐县| 富民县| 瑞金市| 紫金县| 广汉市| 周至县| 怀柔区| 屏东市| 新晃| 铜川市| 亚东县| 噶尔县| 邳州市| 霍州市| 都兰县| 五莲县| 集安市| 南投市| 若尔盖县| 南和县| 醴陵市| 丰宁| 黑山县| 武宁县| 梧州市| 久治县| 上犹县| 资源县| 墨竹工卡县| 儋州市| 滦南县| 祁东县| 哈密市| 青河县| 温泉县| 太保市| 赫章县| 安阳市| 含山县|